Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-05-16 21:36 | 2013-05-09 | ANGO | Angiodynamics Inc. | Greiner Charles R | Officer | SELL | $10.38 | 1,495 | $15,518 | 23,221 |
| 2013-05-16 22:07 | 2013-05-15 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $69.26 | 14,000 | $969,576 | 12,365,682 |
| 2013-05-15 21:46 | 2013-05-14 | OFIX | Orthofix Medical Inc. | Mainelli Michael | Director | BUY | $26.36 | 500 | $13,179 | 6,419 |
| 2013-05-15 21:53 | 2013-05-13 | UFPT | UFP TECHNOLOGIES INC | LESAVOY RICHARD | Officer | SELL | $18.99 | 24,452 | $464,441 | 103,426 |
| 2013-05-15 21:40 | 2013-05-14 | OFIX | Orthofix Medical Inc. | GERO JAMES | Director | BUY | $26.37 | 20,000 | $527,444 | 156,630 |
| 2013-05-16 03:07 | 2013-05-13 | RMD | RESMED INC | QUINN MICHAEL A | Director | SELL | $50.94 | 15,000 | $764,130 | 296,000 |
| 2013-05-14 18:38 | 2013-05-09 | ADMD-OB | VIVOS INC | KATZAROFF JAMES C | Director, Officer, 10% owner | BUY | $0.10 | 14,000 | $1,400 | 2,320,834 |
| 2013-05-15 03:08 | 2013-05-13 | MRIC | ClearPoint Neuro, Inc. | SPENCER JOHN N JR | Director | BUY | $1.32 | 1,500 | $1,980 | 1,500 |
| 2013-05-14 21:05 | 2013-05-13 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $68.78 | 14,000 | $962,949 | 12,379,682 |
| 2013-05-14 17:16 | 2013-05-13 | BDX | BECTON DICKINSON & CO | COHEN GARY M | Officer | OPT+S | $100.22 | 8,753 | $877,226 | 66,577 |
| 2013-05-13 21:32 | 2013-05-10 | MDXG-OB | MIMEDX GROUP, INC. | BLESER JOSEPH G | Director | BUY | $6.50 | 10,500 | $68,250 | 76,085 |
| 2013-05-14 01:59 | 2013-05-09 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Officer | SELL | $19.56 | 1,272 | $24,875 | 91,973 |
| 2013-05-14 01:58 | 2013-05-13 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $19.40 | 45,000 | $873,000 | 144,571 |
| 2013-05-11 02:04 | 2013-05-08 | RMD | RESMED INC | Sandercock Brett | Officer | OPT+S | $48.97 | 28,000 | $1,371,076 | 69,518 |
| 2013-05-10 18:29 | 2013-05-09 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $67.04 | 14,000 | $938,560 | 12,393,682 |
| 2013-05-09 19:10 | 2013-05-08 | SYK | STRYKER CORP | COX HOWARD E JR | Director | SELL | $66.12 | 20,000 | $1,322,454 | 597,957 |
| 2013-05-09 20:31 | 2013-05-07 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $66.21 | 14,000 | $926,920 | 12,407,682 |
| 2013-05-09 21:51 | 2013-05-08 | WST | WEST PHARMACEUTICAL SERVICES INC | JOHNSON L ROBERT | Director | OPT+S | $64.49 | 6,400 | $412,707 | 28,112 |
| 2013-05-08 23:05 | 2013-05-06 | PDEX | PRO DEX INC | Swenson Nicholas John | Director, 10% owner | BUY | $2.00 | 28,206 | $56,412 | 613,418 |
| 2013-05-08 23:05 | 2013-05-06 | PDEX | PRO DEX INC | CABILLOT RAYMOND E | Director | BUY | $2.00 | 28,206 | $56,412 | 247,036 |
| 2013-05-09 00:39 | 2013-05-06 | BSX | BOSTON SCIENTIFIC CORP | MARIO ERNEST | Director | BUY | $7.76 | 30,000 | $232,800 | 509,304 |
| 2013-05-09 00:16 | 2013-05-06 | LMAT | LEMAITRE VASCULAR INC | Linden Robert V | Officer | SELL | $6.10 | 11,941 | $72,815 | 15,905 |
| 2013-05-09 00:15 | 2013-05-07 | LMAT | LEMAITRE VASCULAR INC | Thorndike William N Jr | Director | SELL | $6.04 | 5,051 | $30,515 | 0 |
| 2013-05-08 19:10 | 2013-05-07 | BDX | BECTON DICKINSON & CO | SHERMAN JEFFREY S | Officer | OPT+S | $97.42 | 5,899 | $574,681 | 25,176 |
| 2013-05-08 03:36 | 2013-05-03 | RMD | RESMED INC | Sandercock Brett | Officer | OPT+S | $48.01 | 23,700 | $1,137,719 | 69,518 |
| 2013-05-08 00:36 | 2013-05-03 | GMED | GLOBUS MEDICAL INC | Demski David M | Director, Officer | SELL | $16.25 | 40,000 | $650,000 | 761,365 |
| 2013-05-07 16:33 | 2013-05-06 | MDXG-OB | MIMEDX GROUP, INC. | BLESER JOSEPH G | Director | BUY | $6.50 | 1,000 | $6,500 | 60,585 |
| 2013-05-07 23:17 | 2013-05-03 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | OPT+S | $38.32 | 12,000 | $459,830 | 8,352 |
| 2013-05-06 20:41 | 2013-05-03 | UFPT | UFP TECHNOLOGIES INC | Pierce Robert W Jr | Director | BUY | $19.00 | 3,999 | $75,981 | 34,550 |
| 2013-05-06 20:40 | 2013-05-03 | UFPT | UFP TECHNOLOGIES INC | Stevenson David K | Director | SELL | $19.00 | 3,999 | $75,981 | 14,939 |
| 2013-05-06 18:21 | 2013-05-06 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $66.40 | 7,000 | $464,821 | 12,421,682 |
| 2013-05-06 17:45 | 2013-05-03 | MMM | 3M CO | PALENSKY FRED J | Officer | SELL | $108.33 | 17,572 | $1,903,510 | 29,072 |
| 2013-05-06 17:35 | 2013-05-03 | MMM | 3M CO | PALENSKY FRED J | Officer | OPT+S | $108.27 | 29,409 | $3,184,104 | 46,644 |
| 2013-05-06 23:10 | 2013-05-02 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | OGRADY JUDITH | Officer | SELL | $39.00 | 1,000 | $39,000 | 20,013 |
| 2013-05-06 22:43 | 2013-05-03 | BDX | BECTON DICKINSON & CO | COHEN GARY M | Officer | OPT+S | $96.74 | 23,177 | $2,242,226 | 66,577 |
| 2013-05-04 01:10 | 2013-05-01 | RMD | RESMED INC | Douglas Robert Andrew | Officer | OPT+S | $48.00 | 8,000 | $384,000 | 97,981 |
| 2013-05-04 01:11 | 2013-05-01 | RMD | RESMED INC | Sandercock Brett | Officer | OPT+S | $48.03 | 3,300 | $158,489 | 69,518 |
| 2013-05-03 18:37 | 2013-05-02 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $66.31 | 14,000 | $928,305 | 12,428,682 |
| 2013-05-04 00:35 | 2013-05-01 | PODD | INSULET CORP | DeSisto Duane | Director, Officer | OPT+S | $24.86 | 20,000 | $497,240 | 182,023 |
| 2013-05-03 16:50 | 2013-05-03 | MELA | STRATA Skin Sciences, Inc. | Gulfo Joseph V | Director, Officer | BUY | $1.08 | 25,000 | $27,000 | 208,311 |
| 2013-05-03 02:18 | 2013-04-30 | HAE | HAEMONETICS CORP | Helsel Dave | Officer | BUY | $32.73 | 272 | $8,901 | 6,856 |
| 2013-05-03 02:18 | 2013-04-30 | HAE | HAEMONETICS CORP | Jesse Sandra | Officer | BUY | $32.73 | 614 | $20,093 | 8,680 |
| 2013-05-03 00:02 | 2013-04-30 | PDEX | PRO DEX INC | Swenson Nicholas John | 10% owner | BUY | $2.00 | 5,176 | $10,352 | 585,212 |
| 2013-05-03 02:19 | 2013-04-30 | HAE | HAEMONETICS CORP | White Jonathan | Officer | BUY | $32.73 | 615 | $20,126 | 25,342 |
| 2013-05-02 23:04 | 2013-05-01 | SYK | STRYKER CORP | Carpenter Lonny J | Officer | SELL | $65.53 | 6,000 | $393,172 | 31,101 |
| 2013-05-02 23:05 | 2013-04-30 | PDEX | PRO DEX INC | CABILLOT RAYMOND E | Director | BUY | $2.00 | 5,176 | $10,352 | 218,830 |
| 2013-05-03 02:19 | 2013-04-30 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | Officer | BUY | $32.73 | 412 | $13,483 | 31,522 |
| 2013-05-03 02:18 | 2013-04-30 | HAE | HAEMONETICS CORP | ALLEN PETER M | Officer | BUY | $32.73 | 451 | $14,759 | 26,797 |
| 2013-05-02 22:19 | 2013-05-01 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $38.66 | 13,000 | $502,605 | 115,798 |
| 2013-05-03 02:19 | 2013-04-30 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | Officer | BUY | $32.73 | 615 | $20,126 | 17,279 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.